首页> 外文期刊>European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology >Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs)
【24h】

Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs)

机译:评估成年注意力缺陷和多动障碍(ADHD)和物质使用障碍(SUD)中miR-183-96-182簇中单核苷酸多态性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Attention deficit-hyperactivity disorder (ADHD) is a neuropsychiatric disorder characterized by inappropriate and impaired levels of hyperactivity, impulsivity and inattention. Around 75% of adults with ADHD show comorbidity with other psychiatric disorders such as disruptive behavior disorders or substance use disorders (SUDs). Recently, there has been growing interest in studying the role of microRNAs (miRNAs) in the susceptibility to complex disorders. Interestingly, converging evidence suggests that single nucleotide polymorphisms (SNPs) within miRNAs or miRNA target sites may modulate the miRNA-mediated regulation of gene expression through the alteration of the miRNA maturation, structure or expression pattern as well as the silencing mechanisms of target genes. Genetic studies and animal models support the involvement of the serotonin receptor (HTR1B) in ADHD. We evaluated the contribution of one SNP in the miR-96 target site at HTR1B and eight tagSNPs within the genomic region containing this miRNA in 695 adults with ADHD (266 and 396 subjects with and without comorbid SUD, respectively), 403 subjects with SUD without life-time diagnosis of ADHD and 485 sex-matched controls from Spain. Single and multiple marker analyses revealed association between two SNPs located at the 3' region of miR-96 (rs2402959 and rs6965643) and ADHD without SUD. Our results provide preliminary evidence for the contribution of two sequence variants at the miR-183-96-182 cluster to ADHD without comorbid SUD, and emphasize the need to take comorbidities into account in genetic studies to minimize the effect of heterogeneity and to clarify these complex phenotypes.
机译:注意缺陷多动障碍(ADHD)是一种神经精神疾病,其特征在于过度活跃,冲动和注意力不集中和受损。大约75%患有ADHD的成年人显示出与其他精神疾病合并症,例如破坏性行为障碍或物质使用障碍(SUD)。最近,人们对研究微小RNA(miRNA)在复杂疾病易感性中的作用越来越感兴趣。有趣的是,越来越多的证据表明,miRNA或miRNA靶位点内的单核苷酸多态性(SNP)可能通过改变miRNA的成熟度,结构或表达方式以及靶基因的沉默机制来调节miRNA介导的基因表达调控。遗传研究和动物模型支持血清素受体(HTR1B)参与ADHD。我们评估了695名患有ADHD的成年人(分别有266名和396名患有和未患有共病SUD的成年人),403名患有SUD而未患有SUD的成年人中HTR1B处miR-96目标位点的一个SNP和包含该miRNA的基因组区域中的八个tagSNP的贡献。西班牙对ADHD和485个性别匹配的对照进行终生诊断。单标记和多标记分析表明,位于miR-96 3'区的两个SNP(rs2402959和rs6965643)与无SUD的ADHD之间存在关联。我们的结果提供了miR-183-96-182簇上两个序列变异体对无共病SUD的ADHD的贡献的初步证据,并强调了遗传研究中需要考虑合并症以最小化异质性的影响并阐明这些复杂的表型。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号